FDA.reportPublic FDA data

NDC 0024-5155 - Elitek

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0024-5155
Package NDCs from labels
0024-5155-74
Manufacturer
Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi S.r.l.
Effective date
2025-05-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Elitek - Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi S.r.l.Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi S.r.l.2025-05-08HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0024-5155-74Elitek5 mL in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,5 mL7.5 mg in 5mL23

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0024-5155ELITEK (RASBURICASE) KIT [SANOFI-AVENTIS U.S. LLC]23Unmatched20250515_0ae10bc4-6b65-402f-9db5-2d7753054922.zip